Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-21-006563

EVP R&D, Chief Medical Officer gave up 1,172 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 3,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-16 Option exercise +3,375 18,208 D
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-16 Shares withheld for taxes −1,172 $19.79 $23,194 17,036 D
Derivatives
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-16 Option exercise · Restricted Stock Unit Award −3,375 3,375 D
Loading xslF345X03/form4.xml…